.png){kind=icon}
返回
Influenza
.png){kind=icon}
OA
AI
DOI：10.1038/s41572-018-0002-y.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Influenza is an infectious respiratory disease that, in humans, is caused by influenza A and influenza B viruses. Typically characterized by annual seasonal epidemics, sporadic pandemic outbreaks involve influenza A virus strains of zoonotic origin. The WHO estimates that annual epidemics of influenza result in similar to 1 billion infections, 3-5 million cases of severe illness and 300,000-500,000 deaths. The severity of pandemic influenza depends on multiple factors, including the virulence of the pandemic virus strain and the level of pre-existing immunity. The most severe influenza pandemic, in 1918, resulted in >40 million deaths worldwide. Influenza vaccines are formulated every year to match the circulating strains, as they evolve antigenically owing to antigenic drift. Nevertheless, vaccine efficacy is not optimal and is dramatically low in the case of an antigenic mismatch between the vaccine and the circulating virus strain. Antiviral agents that target the influenza virus enzyme neuraminidase have been developed for prophylaxis and therapy. However, the use of these antivirals is still limited. Emerging approaches to combat influenza include the development of universal influenza virus vaccines that provide protection against antigenically distant influenza viruses, but these vaccines need to be tested in clinical trials to ascertain their effectiveness.
Keyword:
PATHOGENIC AVIAN INFLUENZA
VIRUS NS1 PROTEIN
DEPENDENT CELLULAR CYTOTOXICITY
LIVE POULTRY MARKETS
CD8(+) T-CELLS
A H1N1 VIRUS
H7N9 INFLUENZA
NEURAMINIDASE INHIBITORS
SEASONAL INFLUENZA
PANDEMIC INFLUENZA
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
N
IF:
60.6
论文数:
648
被引数:
3.8W
机构
引用论文
.png){kind=icon}
分享收藏
查看更多内容